CD79α is encoded by the mb-1 gene and was previously called Igα. The antibody recognizes an extracellular epitope expressed on the CD79α molecule. Results aid in the classification of B-cell neoplasms in routine biopsy material. In addition to the expression in B cells, CD79α has been found to be co-expressed with CD3 in 10% of cases of T-lymphoblastic leukemia/lymphoma. Antibodies to CD79α may also be a useful aid for classification of Hodgkin's disease.
This product is not available for purchase by the general public.
Product Details
Features
Excellent specificity
High lot to lot consistency
Optimized for immunohistochemistry (IHC) with validated protocols
Certified manufacturing facilities guarantee full quality control
More than 50 years experience ensuring quality and innovation in antibodies and reagents
Specifications
Application
Formalin
HIER
Clone
JCB117
Code Number
M7050
Immunogen
Recombinant protein containing part of the extracellular portion of the human CD79α glycoprotein (1). See package insert for reference(s).
Isotype
IgG1, kappa
Reagent Provided
Monoclonal mouse antibody provided in liquid form as cell culture supernatant dialysed against 0.05 mol/L Tris-HCl, pH 7.2, and containing 15 mmol/L NaN3.
Solutions
Concentrate
Species
Mouse Anti-Human
Specificity
The antibody was clustered as anti-CD79α at the Sixth International Workshop and Conference on Human Leucocyte Differentiation Antigens held in Kobe in 1996 (4). In Western blotting of Ramos B-cell lysate, the antibody labels a band corresponding to CD79α under reducing conditions, and a band corresponding to CD79αß under non-reducing conditions (1). SDS-PAGE analysis of immunoprecipitates formed between the antibody and 125I-labeled, mildly denatured, and reduced lysate of Ramos B cells, shows weak reaction with a 43 kDa polypeptide corresponding to CD79α.
The antibody was tested by flow cytometry against normal peripheral B-cell lines, and against mature and immature B-cell lines (Ramos, Raji, and NALM-1), and was consistently negative, indicating that the epitope recognized is not present, or is not accessible, on living cells. However, the antibody specifically labels B cells in paraffin-embedded tissue sections (4). See package insert for reference(s).
The focus of the sixth edition of the IHC Guidebook is to provide a comprehensive immunohistochemistry (IHC) resource for lab managers, lab technicians, learning pathologists, and students from around the world.
1. Mason DY, Cordell JL, Brown MH, Borst J, Jones M, Pulford K, et al. CD79a: a novel marker for B-cell neoplasms in routinely processed tissue samples. Blood 1995,86:1453-9. 2. Pilozzi E, Pulford K, Jones M, Muller-Hermelink HK, Falini B, Ralfkiaer E, et al. Co-expression of CD79a (JCB117) and CD3 by lymphoblastic lymphoma. J Pathol 1998,186:140-3. 3. Chu PG, Arber DA. CD79: a review. Appl Immunohistochem Mol Morphol 2001,9:97-106.